2. Clinical aspect of OSNA usage in gynecological and prostate cancers

1. OSNA for detection of sentinel node low-volume metastases in endometrial cancer

Fast and accurate assessment of sentinel lymph nodes (SLN) in endometrial cancer patients allows less radical surgical interventions not compromising staging accuracy. Get insights in more than 2 years experience with OSNA usage.

2. Validation study for the detection of CK19 using pooling method with One-Step Nucleic acid Amplification in prostate cancer (POPCORN study)- Preliminary Results

Meet the experts

Prof. Francesco Fanfani, U.O.C. di Ginecologia Oncologica - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy (speaker)
Dr Merce Cuadras Solé, Urology department, Hospital Universitari Vall d’Hebron, Barcelona, Spain (speaker)
Dr Maria Eugenia Semidey Raven, Pathology department, Hospital Universitary Vall d’Hebron, Barcelona, Spain (speaker)
Monika Zänkert, Product Manager Life Science, Sysmex Europe GmbH, Germany (moderator)
Dr Gabriele Ebling, Product Manager Life Science, Sysmex Europe GmbH, Germany (moderator)